Patient Capital Management’s General Motors GM Stock Holding History

Patient Capital Management’s Portfolio GM Stock Details GM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.7M	Sell	631,558 -113,072	-15%	-$8.88M	1.6%	24
2026 Q1	$55.5M	Sell	744,630 -27,017	-4%	-$2.15M	2.03%	22
2025 Q4	$62.8M	Sell	771,647 -168,950	-18%	-$11.9M	2.42%	19
2025 Q3	$57.3M	Sell	940,597 -4,156	-0.4%	-$232K	2.3%	21
2025 Q2	$46.5M	Sell	944,753 -582,010	-38%	-$27.6M	2.1%	24
2025 Q1	$71.8M	Sell	1,526,763 -4,381	-0.3%	-$216K	3.69%	10
2024 Q4	$81.6M	Sell	1,531,144 -18,930	-1%	-$991K	3.76%	9
2024 Q3	$69.5M	Sell	1,550,074 -88,939	-5%	-$4.12M	3.41%	11
2024 Q2	$76.1M	Sell	1,639,013 -158,759	-9%	-$7.17M	4.04%	7
2024 Q1	$81.5M	Sell	1,797,772 -68,595	-4%	-$2.66M	3.97%	8
2023 Q4	$67M	Buy	1,866,367 +245,062	+15%	+$7.58M	3.55%	10
2023 Q3	$53.5M	Sell	1,621,305 -10,777	-0.7%	-$383K	3.14%	13
2023 Q2	$62.9M	Buy	1,632,082 +1,453,107	+812%	+$50.3M	3.5%	11
2023 Q1	$6.56M	Sell	178,975 -3,725	-2%	-$141K	2.92%	15
2022 Q4	$6.15M	Sell	182,700 -5,000	-3%	-$185K	2.98%	14
2022 Q3	$6.02M	Sell	187,700 -3,800	-2%	-$139K	3.01%	12
2022 Q2	$6.08M	Buy	191,500 +29,100	+18%	+$1.09M	2.69%	15
2022 Q1	$7.1M	Buy	162,400 +5,000	+3%	+$250K	2.41%	16
2021 Q4	$9.23M	Buy	+157,400	New	+$9.2M	2.66%	9

Other funds holding GM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Patient Capital Management's GM Position: Q2 2026 in Review

Patient Capital Management reduced its General Motors (GM) stake by 15% in Q2 2026, selling an estimated $8.88M and leaving 631,558 shares worth $48.7M. The position accounts for 1.6% of the portfolio, ranked #24.

Patient Capital Management first reported a position in GM in Q4 2021 and has held it in 19 quarters since. The position peaked at $81.6M in Q4 2024. 1,569 funds tracked by Wall St. Rank hold GM as of Q2 2026.

Patient Capital Management held 631,558 shares of General Motors worth $48.7M as of Q2 2026.
Patient Capital Management sold 113,072 General Motors shares in Q2 2026, an estimated $8.88M.
General Motors made up 1.6% of Patient Capital Management's portfolio in Q2 2026, its #24 holding.
Patient Capital Management first reported a position in General Motors in Q4 2021 and has held it in 19 quarters since.
Patient Capital Management's General Motors position peaked at $81.6M in Q4 2024.
1,569 funds tracked by Wall St. Rank held General Motors as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.